117 Results for 'Donald E. Ingber'
Microfluidic encapsulation for subcutaneous delivery of viscous drugs
Antibodies and other biopharmaceuticals have emerged as a powerful new class of drugs for treating diseases that range from rheumatoid arthritis to breast cancer to macular degeneration. However, these large, protein-based molecules cannot be taken orally (the stomach would digest them) and are frequently given at high concentrations. Most are administered intravenously, but that approach...
Tethered Liquid Perfluorocarbon (TLP), a non-stick coating for medical devices
Every device implanted in the body or in contact with flowing blood faces two critical challenges that can threaten the life of the patient it is meant to help: blood clotting and bacterial infection. To confront this challenge, Wyss Institute researchers created a super-repellent, Thin Layer Perfluorocarbon (TLP) coating specifically designed to prevent clot formation...
Over 15 million Americans are at risk of anaphylaxis, a severe allergic reaction triggered by exposure to certain foods, materials, medications and insect bites. Every three minutes a food reaction sends someone to the emergency room. In most individuals, anaphylactic shock can be prevented by administering the counteracting drug, epinephrine. Yet, despite effective treatments, death from...
Shrilk Biodegradable Plastic
Wyss Institute researchers have developed a fully degradable bioplastic by isolating a material called chitosan found in shrimp shells and forming a laminate with silk fibroin protein that mimics the microarchitecture of natural insect cuticle. The new material, called “Shrilk”, can be used to manufacture objects without the environmental threat posed by conventional synthetic plastics,...
Pathogen Capture Technology for Infectious Disease Therapeutics and Diagnostics
Microbial contamination is the cause of life-threatening cases of sepsis, meningitis and multiple other infectious diseases that are a major cause of death world-wide. Equally prevalent are pathogenic contaminants in our environment, food, and manufacturing processes. In each case, the presence of microbial contaminants must be confirmed, and when they are found, they need to...
Mechanically-Activated Drug Targeting Nanotechnology
The Wyss team has developed a novel drug targeting nanotechnology that is activated locally by mechanical forces, either endogenous high shear stresses in blood created by vascular occlusion or mechanical energy applied locally using low-energy ultrasound radiation. Today, vascular blockage is the leading cause of death and disability in United States and Europe. Current therapies...
May 22, 2017, 1:00pm - 2:00pm
- Add to Calendar
- Google Calendar
Wyss Institute Founding Director Donald E. Ingber, M.D., Ph.D., will discuss the potential for human organs on chips to revolutionize drug trials at Brigham and Women’s Hospital’s Pathology Grand Rounds seminar series on Monday, May 22. Accreditation Information Partners HealthCare System is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education... Free and open to public